DrugDashboards

Escitalopram Oxalate

Escitalopram Oxalate · ESCITALOPRAM OXALATE 5 mg/5mL · Solution · Oral · Aurobindo Pharma Limited

NDC 65862-0248-24 · 240 mL in 1 BOTTLE · ANDA · View full market →

The short version

4 companies supply this market — a reasonable cushion if one runs into trouble. The price has held steady around $0.4566 per unit over the past year.

The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.

One drug, every price

The same NDC has different prices depending on who is paying. Units differ between rungs — compare within a rung over time, not rung against rung, unless the units match.

ⓘ How this was built
Data sources
  • CMS NADAC (pharmacy acquisition, weekly)
  • CMS Part B ASP quarterly payment limits
  • CMS Maximum Fair Prices (IRA negotiated, NDC-level)
  • Medicare Part D Spending by Drug (data.cms.gov, name-matched)
  • VA FSS / Big4 federal contract prices (va.gov, twice monthly)
  • ACA Federal Upper Limits + weighted AMP (data.medicaid.gov, monthly)
  • California SB-17 WAC filings (list price, per package)
Method

Each rung is the newest figure for this NDC from one federal price system, shown with its own unit. Part D is matched by drug name because CMS publishes no NDCs there; it is gross spending, before confidential rebates.

Pipeline and calculations built by Claude (Fable 5) from the public datasets above. Educational only — verify against primary sources before acting.

  • Part D plans paid (avg)$0.1903per dosage unitgross, before rebates — matched by drug name · 2024
  • Medicaid generic ceiling (FUL)$0.5093per MLweighted avg manufacturer price $0.1618 · Dec 1, 2016

Medicare Part D

No Medicare Part D plan in CMS's quarterly files lists this product. That usually means it is discontinued, a repackager's listing, or a product no plan has added to its formulary.

How Part D pricing works →

NADAC price per unit

$0$0.25$0.5$0.75Nov 2013Feb 2017$0.4566
39 price points · per · last surveyed Invalid Date · dashed = manufacturer avg (WAMP)Source: CMS NADAC

Estimated fill cost

WAC per package, as filed
$152.16
Reported to Texas DSHS · 2026 annual filing · Aurobindo Pharma Usa, Inc.

Manufacturer list price as filed — not what pharmacies actually pay after discounts.

Supply fragility

Not scored — fragility is computed for NADAC-priced NDCs.

90-day shortage risk (model v2)

0.1%chance of a new FDA shortage posting for escitalopram oxalate (other) in the next 90 days

sole-source market

For scale: the typical drug’s chance is about 0.1% — this one is in ordinary territory.

Backtested statistical model over the whole market, not this package alone. Model details →

Where it's made

Establishments this product's FDA label declares, located via FDA registration data. How we built this →

Regulatory

Application
ANDA079062
TE code
AA
Approval date
Apr 2, 2012
Patents / exclusivity
None on file

Shortage history

No FDA shortage reports for this drug or its presentations.

Recalls (this NDC)

No enforcement reports list this package NDC.

Manufacturers of Escitalopram Oxalate (Solution)

LabelerStrengthFirst seenLast seen
Aurobindo Pharma LimitedESCITALOPRAM OXALATE 5 mg/5mLJul 15, 2026Sep 2, 2026
Camber Pharmaceuticals, Inc.ESCITALOPRAM OXALATE 5 mg/5mLJul 15, 2026Sep 2, 2026
Rising Pharma Holdings, Inc.ESCITALOPRAM OXALATE 5 mg/5mLJul 15, 2026Sep 2, 2026
Sun Pharmaceutical Industries, Inc.ESCITALOPRAM OXALATE 5 mg/5mLJul 15, 2026Sep 2, 2026

Roster from daily NDC Directory diffs — first/last seen dates start July 2026.

Cite this page

DrugDashboards, "Escitalopram Oxalate — NDC 65862-0248-24," retrieved September 3, 2026, https://drugdashboards.com/drug/65862024824.

Free to cite with attribution — see how the data is put together.